Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
10/2008
10/23/2008US20080261977 Pyrimidine Derivatives as Cannabinoid Receptor Modulators
10/23/2008US20080261968 Heterobicyclic metalloprotease inhibitors
10/23/2008US20080260754 Prevent transplant rejection; autoimmune diseases
10/23/2008CA2684470A1 Pyrimidine derivatives
10/23/2008CA2683694A1 Process for the preparation of gefitinib
10/23/2008CA2683049A1 Organic compounds
10/23/2008CA2682817A1 Pyrimidinyl-piperazines useful as d3/d2 receptor ligands
10/23/2008CA2682733A1 Axl kinase inhibitors
10/22/2008EP1982980A1 Crystalline form of risperidone
10/22/2008EP1982718A1 Anti-cancer pharmaceutical composition
10/22/2008EP1981856A2 Pyrimidine derivatives
10/22/2008EP1981855A2 Substituted bis-amide metalloprotease inhibitors
10/22/2008EP1981852A1 Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists
10/22/2008EP1981837A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
10/22/2008EP1677599A4 Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors
10/22/2008EP1458394B1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3
10/22/2008CN101291917A Diaryl urea derivatives in the treatment of protein kinase dependent diseases
10/22/2008CN101291908A Immunosuppressant compounds and compositions
10/21/2008US7439400 Amino alcohol ligand and its use in preparation of chiral proparglic tertiary alcohols and tertiary amines via enantioselective addition reaction
10/21/2008US7439393 Phenethanolamine derivatives for treatment of respiratory diseases
10/21/2008US7439358 Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
10/21/2008US7439345 Supramolecular pairing system, its preparation and use
10/21/2008US7439250 such as lipoasparagine; liposomes
10/21/2008US7439249 such as 2-(7-acetylamino-1-furano-2-ylmethyl-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-succinic acid; for treatment of autoimmune diseases, proliferative diseases, angiogenic disorders, and/or cancers; catheters, prosthetics
10/16/2008WO2008124826A1 Methods for treating cancer
10/16/2008WO2008124824A1 Dosages and methods for the treatment of cancer
10/16/2008WO2008124823A1 Method of treating melanoma
10/16/2008WO2008124610A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/16/2008WO2008124532A1 Quinazolinone derivatives as aldh-2 inhibitors
10/16/2008WO2008123779A1 Trisubstituted triazamacrocycli c compounds and their use as contrast agents
10/16/2008WO2008122787A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
10/16/2008WO2008122776A2 Process for preparation of erlotinib and its pharmaceutically acceptable salts
10/16/2008WO2008079988A3 Quinazolines for pdk1 inhibition
10/16/2008WO2008057862A3 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
10/16/2008WO2007130783A3 Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
10/16/2008US20080255356 5,5'-bis(disubstitutedphosphino)-1,1',3,3'-tetraalkyl-4,4'-bipyrimidine-2,2',6,6'-(1H,1'H,3H,3'H)-tetrone used as as ligands to generate chiral transition metal catalysts, for asymmetric allylic substitution reactions
10/16/2008US20080255170 Process for the Synthesis of Rosuvastatin Calcium
10/16/2008US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread
10/16/2008US20080255166 E.g., 5-dinitro-2-dimethyldithio-carbamoyl-pyridine; strong bacteriacidal activity, especially against mycobacteria; tuberculosis and leprosy caused by mycobacteria and infectious diseases caused by staphylococci; side effect reductions; effective against drug, multidrug-resistant infections
10/16/2008US20080255164 2-amino-6-(3-bromo-4-chlorophenyl)-5,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one trifluoroacetate; prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia
10/16/2008US20080255161 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/16/2008US20080255155 Inhibit protein tyrosine kinase; treating cell proliferative diseases and conditions; N-(6-(2-Fluoro-4-(4,4,4-trifluoro-3-(4-fluorophenylamino)butanamido)phenoxy)pyrimidin-4-yl)pyrrolidine-1-carboxamide
10/16/2008US20080255118 Cyanopyrimidinones
10/16/2008US20080255111 (4'-{[2-(tert-Butoxycarbonyl)-3-hydroxy-4-(trifluoromethyl)benzyl]oxy}-1,1'-biphenyl-4-yl)acetic acid; vascular restenosis following angioplasty, endarterectomy, percutaneous transluminal coronary angioplasty (PTCA) or stent implantation, blood coagulation diseases
10/16/2008CA2720989A1 Methods for treating cancer
10/16/2008CA2720987A1 Dosages and methods for the treatment of cancer
10/16/2008CA2720983A1 Method of treating melanoma
10/16/2008CA2683431A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/16/2008CA2682207A1 Quinazolinone derivatives as aldh-2 inhibitors
10/16/2008CA2682013A1 Process for preparation of erlotinib and its pharmaceutically acceptable salts
10/15/2008EP1979331A1 Trisubstituted amine compounds as inhibitors of -cholesteryl ester transfer protein cetp
10/15/2008EP1979330A2 A process for manufacturing rosuvastatin potassium
10/15/2008EP1979329A2 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and methods of use
10/15/2008EP1979328A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
10/15/2008EP1979327A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
10/15/2008EP1979326A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
10/15/2008EP1979325A1 Morpholino pyrimidine derivatives and their use in therapy
10/15/2008EP1979320A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/15/2008EP1899306B1 Chloro-substituted guanidines
10/15/2008EP1476423B1 Arylsulfonamidobenzylic compounds
10/15/2008EP1417264B1 Novel azo pigments
10/15/2008EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/15/2008EP1296995B1 3'-prodrugs of 2'-deoxy-beta-l-nucleosides
10/15/2008CN101287715A Amide derivatives
10/15/2008CN101287714A Dihydrogen phosphate salt of a prostaglandin d2 receptor antagonist
10/15/2008CN101284247A Dinuclear nickel cross-coupling reaction catalyst supported by nitrogen heterocycle carbine ligand and preparation method thereof
10/15/2008CN101283684A Application of a compound for preventing and controlling cucumber fusarium wilt and tomato gray mold
10/15/2008CN100425595C 2-substituted pyrimidines
10/14/2008US7435823 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/14/2008US7435814 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
10/14/2008US7435740 e.g. 1-Benzyl-7-phenyl-3-propyl-1H-pyrrolo[1,2-f]purine-2,4(3H,6H)-dione; antiinflammatory, anticarcinogenic agent; cerebral ischemia, asthma, neurodegeneration, glaucoma, ischemic heart pre-conditioning; diagnostic agents
10/14/2008US7435734 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; inhibitors of HIV replication; with other HIV/AIDS antivirals, anti-infectives, immunomodulators, antibiotics or vaccines; AIDS
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/09/2008WO2008121670A1 Pyrimidine hydrazide compounds as pgds inhibitors
10/09/2008WO2008120235A1 Novel benzophenone hybrids as potential anticancer agents and a process for the preparation thereof
10/09/2008WO2008120093A1 Sulfonamides and pharmaceutical compositions thereof
10/09/2008WO2008119810A2 Processes for the preparation of statins, particularly rosuvastatin, and intermediates for the preparation thereof
10/09/2008WO2008093272A3 Controlled release of active aldehydes and ketones from equilibrated dynamic mixtures
10/09/2008WO2008062276A8 Acetylene derivatives as stearoyl coa desaturase inhibitors
10/09/2008WO2008057873A3 Inhibitors of hepatitis c virus
10/09/2008WO2008057871A3 Inhibitors of hepatitis c virus
10/09/2008WO2008050301A3 2- phenyl- 6-aminocarbonyl- pyrimidine derivatives and their use as p2y12 receptor antagonists
10/09/2008US20080249306 Method for the Production of Statins
10/09/2008US20080249304 Process for preparing substituted diaminopyrimidine oximes
10/09/2008US20080249120 Pharmaceutical compositions
10/09/2008US20080249116 Aldehyde dehydrogenase; 3-(4-hydroxyphenyl)-7-[(5-phenyl(1,2,4-oxadiazol-3-yl))methoxy]-3-hydroquinazolin-4-one; alcoholism; cocaine and nicotine addictions
10/09/2008US20080249112 Antiproliferavtive agents; small molecule inhibitors of KSP(kinesin-related proteins); N-(3-aminopropyl)-N-[1-(3-benzyl-4-oxo-6,7,8 ,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-2-yl)propyl]-4-bromobenzamide
10/09/2008US20080249071 inhibitory activity against the activation of inflammatory cytokines such as interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor (TNF- alpha ), NF- kappa K B; inflammatory disorders, autoimmune diseases; side effects reduction; immuno suressants; N-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxybenzamide
10/09/2008US20080247991 Solution Additives For the Attenuation of Protein Aggregation
10/09/2008US20080246002 Polar liquid crystal
10/09/2008CA2682629A1 Pyrimidine hydrazide compounds as pgds inhibitors
10/09/2008CA2682384A1 Benzophenone hybrids as potential anticancer agents and a process for the preparation thereof
10/08/2008EP1978020A1 Processes for the preparation of statins, particularly rosuvastatin, and intermediates for the preparation thereof
10/08/2008EP1976847A2 Pyrimidinyl aryl urea derivatives being fgf inhibitors
10/08/2008EP1976836A2 Nitrogen-containing bicyclic heteroaryl compounds for the treatment of raf protein kinase-mediated diseases
10/08/2008EP1341785B1 Hydrolysis of r(r*,r*)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- [(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid esters with calcium hydroxide
10/08/2008EP1283042B1 Aqueous liquid preparation of pranoprofen
10/08/2008CN101282972A Piperidine and piperazine derivatives as P2X3 antagonists
10/08/2008CN101282945A Compositions and methods for inhibition of the JAK pathway
10/08/2008CN101282944A Crystalline rosuvastatin intermediate
1 ... 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 ... 427